Skip to main content
SpringerLink
Log in

Arzneimittelbehandlung im Alter

  • EDITORIAL
  • Published:
Zeitschrift für Gerontologie und Geriatrie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Callahan CM, Kroenke K, Counsell SR et al for the IMPACT Investigators (2005) Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc 53:367–373

    Article  PubMed  Google Scholar 

  2. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310

    Article  CAS  Google Scholar 

  3. Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V. AWMFonline: Allgemeine Grundsätze für den Einsatz von Arzneimitteln—Leitlinie zur Pharmakotherapie—(http://www.uni-duesseldorf.de/AWMF/II/pharm001.htm)

  4. Field TS, Gurwitz JH, Harrold LR et al (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349–1354

    Article  PubMed  Google Scholar 

  5. Gandhi TK, Weingart SN, Borus J et al (2003) Adverse drug events in ambulatory care. N Engl J Med 348:1556–1564

    Article  PubMed  Google Scholar 

  6. Hasford J, Schubert I, Garbe E, Dietlein G, Glaeske G (2004) Memorandum zu Nutzen und Notwendigkeit pharmakoepidemiologischer Datenbanken in Deutschland. Schriftenreihe zur Gesundheitsanalyse, Band 33. GEK Edition, München Schwäbisch Gmünd

  7. High K, Bradley S, Loeb M, Palmer R, Quagliarello V (2005) A new paradigm for clinical investigation of infectious syndromes in older adults: assessing functional status as a risk factor and outcome measure. J Am Geriatr Soc 53:528–535

    Article  PubMed  Google Scholar 

  8. Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A (2005) Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet 365:434–441

    CAS  PubMed  Google Scholar 

  9. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt H-P, van den Bussche H (2005) Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomized clinical trials. Br Med J (im Druck)

  10. Kaiser T, Florack C, Franz H, Sawicki PT (2005) Donepezil bei Patienten mit Alzheimer-Demenz—Die AD2000-Studie. Med Klin 100:157–160

    Article  Google Scholar 

  11. Kruse W (1994) Medikamente in der Geriatrie: Probleme bei der Arzneimittelanwendung und Lösungsmöglichkeiten. Schriftenreihe des Bundesministeriums für Familie und Senioren, Band 25, S 76–83

    Google Scholar 

  12. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. psychotropic drugs. J Am Geriatr Soc 47:30–39

    CAS  PubMed  Google Scholar 

  13. Levy G (1993) A pharmacokinetic perspective on medicament noncompliance. Clin Pharmacol Ther 54:242–244

    CAS  PubMed  Google Scholar 

  14. Lonergan ET (ed) (1991) Extending life, enhancing life: a national research agenda on aging. National Academy Press, Washington, DC

  15. Nink K, Schröder H (2004) Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report 2004. Springer, Berlin Heidelberg, S 1099–1111

  16. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabai R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from The Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962–1968

    Article  PubMed  Google Scholar 

  17. Pittrow D, Krappweis J, Kirch W (2002) Arzneimittelanwendung bei Alten- und Pflegeheimbewohnern im Vergleich zu Patienten in ambulanter Pflege bzw. ohne Pflegebedarf. Dtsch Med Wochenschr 127:1995–2000

    Article  CAS  PubMed  Google Scholar 

  18. Renteln-Kruse W v (2000) Pharmakoepidemiologie und Erkenntnisse zur Arzneimitteltherapie im Alter. In: Schubert I, Ihle P (Hrsg) Entdeckungspfade des Public Health – Versorgungsepidemiologie und Qualitätszirkel. Bundesverband der Betriebskrankenkassen, Essen. Wissenschaftsverlag NW, Verlag für neue Wissenschaften GmbH, Bremerhaven, S 113–130

  19. Renteln-Kruse W v (2004) Iatrogene Störungen. In: Renteln-Kruse W v (Hrsg) Medizin des Alterns und des alten Menschen. Steinkopff, Darmstadt, S 67–78

  20. Schillinger W, Hermann HP, Hasenfuß G (2004) Differenzialtherapie derHerzinsuffizienz. Internist 45:1378–1387

    Article  CAS  PubMed  Google Scholar 

  21. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling A-K, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:285–291

    Article  PubMed  Google Scholar 

  22. Simon SR, Chan A, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Elston Lafata J, Davis RL, Gurwitz JH (2005) Potentially inappropriate medication use by elderly persons in the US health maintenance organizations, 2000–2001. J Am Geriatr Soc 53:227–232

    Article  PubMed  Google Scholar 

  23. Stryer D, Clancy C (2005) Patients’ safety. Progress is elusive because culture in health care has not changed. Br Med J 330:553–554

    Google Scholar 

  24. Tinetti ME, Bogardus Jr ST, Agostino JV (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351:2870–2874

    Article  CAS  PubMed  Google Scholar 

  25. Usher C, Bennett K, Feely J (2004) Evidence for a gender and age inequality in the prescribing of preventive cardiovascular therapies to the elderly in primary care. J Am Geriatr Soc 33:500–502

    Google Scholar 

  26. Vass M, Avlund K, Lauridsen J, Hendriksen C (2005) Feasible model for prevention of functional decline in older people: municipality-randomized, controlled trial. J Am Geriatr Soc (im Druck)

    Google Scholar 

  27. Vilches A, Suman A (2004) Awareness of over-the-counter drug use by elderly patients. A hospital-based questionnaire survey. Age Ageing 33:205

    Article  CAS  PubMed  Google Scholar 

  28. Wald NJ, Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. Br Med J 326:1419

    CAS  Google Scholar 

  29. Williams IE, Junius U, Jones D, Vass M for the STEP panel members (2002) An evidence-based approach to assessing older people in primary care. Occas Paper R Coll Gen Pract, pp 1–53

  30. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD (1995) The quality in Australien health care study. Med J Aust 163:458–471

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinisch-Geriatrische Klinik, Albertinen-Haus, Zentrum für Geriatrie und Gerontologie, Wiss. Einrichtung an der Universität Hamburg, Sellhopsweg 18–22, 22459, Hamburg, Germany

    W. v. Renteln-Kruse

Authors
  1. W. v. Renteln-Kruse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

v. Renteln-Kruse, W. Arzneimittelbehandlung im Alter. Z Gerontol Geriatr 38, 169–172 (2005). https://doi.org/10.1007/s00391-005-0307-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00391-005-0307-9

Search

Navigation